Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial Source: ERJ Open Res, 7 (4) 00314-2021; 10.1183/23120541.00314-2021 Year: 2021
Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome Year: 2016
Impact of whole body vibration training on balance and muscle power in patients with severe COPD – A randomized, controlled trial Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases Year: 2016
Effect of travelling to 2590m on 6-minute walk distance, blood gases and symptoms of acute mountain sickness in COPD patients Source: International Congress 2014 – COPD: points to ponder Year: 2014
Reduced submaximal exercise performance in COPD patients at moderate altitude (2590m) Source: International Congress 2014 – Clinical exercise physiology in health and COPD Year: 2014
An auto-titrating intelligent oxygen therapy (iO2T) system in COPD patients: A randomised cross-over trial Source: International Congress 2015 – Tele-rehabilitation in chronic lung diseases Year: 2015
Low load / high repetition elastic band resistance training in patients with COPD – A randomized controlled multicenter trial Source: International Congress 2014 – Exercise training and physical activity in patients with COPD Year: 2014
Effects of a training program including downhill walking in COPD: A randomized controlled trial Source: International Congress 2016 – Best abstracts on the role of exercise and physical activity in chronic respiratory disease Year: 2016
Improving physical activity in patients with severe COPD with urban walking circuits. A randomised trial Source: Annual Congress 2013 –New insights in the assessment of physical activity in daily life in patients with COPD, asthmatics and smokers Year: 2013
Effects of a combination of vilanterol and umeclidinium on exercise endurance in subjects with COPD: Two randomised clinical trials Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013
Effects of acetazolamide on exercise performance in patients with COPD at high altitude. RCT. Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019
Altitude related adverse health effects in lowlanders with COPD travelling to 3200m Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems Year: 2016
Cerebral oxygenation in lowlanders with COPD spending a night at 2590m Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016
Effects of supplemental oxygen vs. room air in COPD patients: A randomized placebo-controlled trial Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015
The major limitation to exercise tolerance in COPD patients at Bogota (2640m) is hypoxemia Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010
Effects of a 6 week whole-body vibration training (WBVT) in stable COPD patients: A randomized clinical trial Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016
Effect of hyperoxia on exercise performance in COPD: Randomized trial Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016
Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015
Efficacy and safety of abediterol (LAS100977) in stable asthma: Phase II, randomized, crossover study Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013